palle valentiner-branth at Statens Serum Institut - Research Interests, Publications & Academic Profile

palle valentiner-branth

Head

Statens Serum Institut

Denmark

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Chinese students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Epidemiology

80%

Virology

20%

Immunization

40%

Influenza Research

30%

Public Health

30%

Case-control Study

30%

Vaccinology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trial

Article Link

Year:

2023

Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake (NUDGE-FLU): Study Protocol for a Nationwide Randomized Implementation Trial

Article Link

Year:

2023

Sociodemographic differences in Covid-19 vaccine uptake in Denmark: a nationwide register-based cohort study

Article Link

Year:

2023

The Effect of Electronic Nudges on Influenza Vaccination Rate in Older Adults With Cardiovascular Disease: a Prespecified Analysis of the NUDGE-FLU Trial

Article Link

Year:

2023

Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease among 948,263 individuals ≥ 65 years of age: a Danish cohort study

Article Link

Year:

2022

Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark

Article Link

Year:

2022

COVID-19 preventive measures coincided with a marked decline in other infectious diseases in Denmark, spring 2020

Article Link

Year:

2022

Comorbidity Increases the Risk of Invasive Meningococcal Disease in Adults

Article Link

Year:

2022

Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study

Article Link

Year:

2022

Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial

Article Link

Year:

2022

Collaborators4

Tine Dalby

Statens Serum Institut

DENMARK

Andreas Petersen

Statens Serum Institut

DENMARK

Lasse Engbo Christiansen

Technical University of Denmark

DENMARK

Anders Rhod Larsen

Head of the National Reference laboratory for antimicrobial resistance and staphylococci

Statens Serum Institut

DENMARK

How do Chinese students reach out?

Meet Kite AI